Signaturefd LLC increases its stake in Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)

0

Signaturefd LLC increased its stake in the shares of Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) by 26.4% in the first quarter, Participation channel reports. The company held 2,190 shares of the company after acquiring an additional 458 shares during the period. Signaturefd LLC’s holdings in Fresenius Medical Care AG & Co. KGaA were worth $74,000 at the end of the last quarter.

Other major investors have also recently changed their positions in the company. Creative Financial Designs Inc. ADV purchased a new stake in shares of Fresenius Medical Care AG & Co. KGaA during the first quarter at a value of $67,000. GHP Investment Advisors Inc. purchased a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the first quarter, valued at approximately $72,000. Northwestern Mutual Wealth Management Co. increased its holdings of shares of Fresenius Medical Care AG & Co. KGaA by 223.0% in the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 3,976 shares of the company valued at $129,000 after acquiring 2,745 additional shares last quarter. Johnson Financial Group Inc. purchased a new stake in shares of Fresenius Medical Care AG & Co. KGaA in the fourth quarter, valued at approximately $155,000. Finally, UMB Bank NA MO purchased a new equity stake in Fresenius Medical Care AG & Co. KGaA in the fourth quarter valued at approximately $192,000. 4.73% of the shares are held by hedge funds and other institutional investors.

Analysts set new price targets

Several research companies have recently weighed in on FMS. StockNews.com downgraded Fresenius Medical Care AG & Co. KGaA from a “strong buy” rating to a “buy” rating in a Friday, July 15 report. JPMorgan Chase & Co. raised its price target on Fresenius Medical Care AG & Co. KGaA from €48.70 ($49.69) to €51.00 ($52.04) and assigned the company a rating “underweight” in a Thursday, May 5, report. Truist Financial lowered its price target on Fresenius Medical Care AG & Co. KGaA from $34.00 to $27.00 and set a “holding” rating for the company in a Wednesday, June 22 report. Finally, Jefferies Financial Group upgraded Fresenius Medical Care AG & Co. KGaA from an “underperform” rating to a “buy” rating and raised its price target for the company from $30.30 to $33.70. in a Monday, June 27 report. One research analyst rated the stock with a sell rating, six gave the company’s stock a hold rating and four gave the company’s stock a buy rating. According to data from MarketBeat, Fresenius Medical Care AG & Co. KGaA currently has an average rating of “Hold” and a consensus price target of $52.51.

Pricing performance of Fresenius Medical Care AG & Co. KGaA

Shares of FMS inventory opened at $22.49 on Thursday. Fresenius Medical Care AG & Co. KGaA has a fifty-two week minimum of $22.06 and a fifty-two week maximum of $41.38. The company has a market capitalization of $13.18 billion, a price/earnings ratio of 12.85, a PEG ratio of 0.96 and a beta of 1.21. The company has a debt ratio of 0.51, a quick ratio of 0.93 and a current ratio of 1.26. The stock’s 50-day simple moving average is $25.97 and its 200-day simple moving average is $30.33.

Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating) last released its quarterly results on Wednesday, May 4. The company reported earnings per share of $0.38 for the quarter, beating analyst consensus estimates of $0.30 by $0.08. Fresenius Medical Care AG & Co. KGaA achieved a return on equity of 6.99% and a net margin of 4.91%. The company posted revenue of $5.10 billion for the quarter, versus analyst estimates of $4.97 billion. As a group, stock analysts expect Fresenius Medical Care AG & Co. KGaA to post earnings per share of 1.82 for the current fiscal year.

Fresenius Medical Care AG & Co. KGaA reduces its dividend

The company also recently declared an annual dividend, which was paid on Friday, May 27. Shareholders of record on Monday, May 16 received a dividend of $0.7093 per share. The ex-dividend date was Friday, May 13. This represents a dividend yield of 3.4%. The payout rate of Fresenius Medical Care AG & Co. KGaA is 28.00%.

About Fresenius Medical Care AG & Co. KGaA

(Get a rating)

Fresenius Medical Care AG & Co KGaA provides dialysis care and related dialysis care services in Germany, North America and abroad. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; equipment, training and patient support services including clinical monitoring, assisting with follow-up and arranging delivery of supplies to the patient’s home; and contracted dialysis services with hospitals in the United States for hospitalized patients with end-stage renal disease (ESRD) and for patients with acute renal failure.

Further reading

Want to see which other hedge funds hold FMS? Visit HoldingsChannel.com for the latest 13F reports and insider trading for Fresenius Medical Care AG & Co. KGaA (New York Stock Exchange: FMSGet a rating).

Institutional ownership by quarter for Fresenius Medical Care AG & Co. KGaA (NYSE: FMS)



Get news and reviews for Fresenius Medical Care AG & Co. KGaA Daily – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Fresenius Medical Care AG & Co. KGaA and related companies with MarketBeat.com’s free daily email newsletter .

Share.

Comments are closed.